Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adult Liver Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT00746655
What this trial is testing

SBRT + TACE for Primary Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
University of Pittsburgh
Testing effectiveness (Phase 2)Study completedNCT00875615
What this trial is testing

Cisplatin or Carboplatin and Sorafenib in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery

Who this might be right for
Liver Cancer
University of Miami 11
Early research (Phase 1)Active Not RecruitingNCT02817633
What this trial is testing

TSR-022 in Participants With Advanced Solid Tumors (AMBER)

Who this might be right for
Neoplasms
Tesaro, Inc. 463
Testing effectiveness (Phase 2)WithdrawnNCT02946138
What this trial is testing

Phase II Trial of Carbon-ion Radiotherapy Combined With GM-CSF for the Treatment of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Shanghai Proton and Heavy Ion Center
Not applicableStudy completedNCT07349576
What this trial is testing

Precision Dietary Intervention Improves Postoperative Energy Intake, Nutritional Status, and Recovery in Patients Undergoing Hepatectomy for Liver Cancer: A Randomized Controlled Trial

Who this might be right for
Primary Liver Cancer
Anhui Provincial Hospital 139
Not applicableLooking for participantsNCT06909708
What this trial is testing

SIRT Versus cTACE for Unresectable HCC (CHANCE2506)

Who this might be right for
Unresectable Hepatocellular Carcinoma
Zhongda Hospital 108
Not applicableUnknownNCT05913583
What this trial is testing

Correlation Between Pre-transplant ICI Exposure and Post-transplant Graft Rejection

Who this might be right for
Graft RejectionHepatocellular CarcinomaImmunotherapy+1 more
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 160
Testing effectiveness (Phase 2)Study completedNCT00483405
What this trial is testing

Oxaliplatin, Capecitabine, and Cetuximab in Treating Patients With Advanced Liver Cancer

Who this might be right for
Liver Cancer
UNC Lineberger Comprehensive Cancer Center 33
Not applicableActive Not RecruitingNCT04390724
What this trial is testing

Optimizing Y90 Therapy for Radiation Lobectomy

Who this might be right for
HCCResectionTransplant+2 more
Northwestern University 104
Not applicableStudy completedNCT01043523
What this trial is testing

Liver MRI With Primovist/Eovist in Pediatric Subjects Who Are Suspected or Have Focal Liver Lesions.

Who this might be right for
Liver NeoplasmsAdenomaCarcinoma+1 more
Bayer 52
Large-scale testing (Phase 3)UnknownNCT03469479
What this trial is testing

Neoadjuvant HAIC for Resectable Hepatocellular Carcinoma Beyond Milan Criteria

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 252
Not applicableUnknownNCT01281683
What this trial is testing

Dynamic Contrast-enhanced Magnetic Resonance Imaging in Evaluation of Liver Functional Status and Treatment Efficacy in Patients With Hepatocellular Carcinoma After Locoregional Therapy

Who this might be right for
Hepatocellular Carcinoma
National Taiwan University Hospital 60
Early research (Phase 1)Looking for participantsNCT07369505
What this trial is testing

Sapu003 in Advanced mTOR-sensitive Solid Tumors

Who this might be right for
Breast Cancer MetastaticRenal Cell Carcinoma (RCC)Neuroendocrine Tumors+2 more
SAPU NANO (US) LLC 27
Testing effectiveness (Phase 2)Study completedNCT00321594
What this trial is testing

Belinostat in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more
National Cancer Institute (NCI) 54
Early research (Phase 1)Looking for participantsNCT05488522
What this trial is testing

SBRT With Atezo/Bev for HCC

Who this might be right for
Hepatocellular Carcinoma
Abramson Cancer Center at Penn Medicine 18
Not applicableEnded earlyNCT05184283
What this trial is testing

Utilization of MAsS in Patients Undergoing LT for HCC

Who this might be right for
NAFLDHepatocellular CarcinomaLiver Diseases+3 more
Columbia University 11
Testing effectiveness (Phase 2)UnknownNCT02839954
What this trial is testing

CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor

Who this might be right for
Hepatocellular CarcinomaNon-small Cell Lung CancerPancreatic Carcinoma+4 more
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Testing effectiveness (Phase 2)Ended earlyNCT02102022
What this trial is testing

Ph 1-2 Study ADI-PEG 20 Plus FOLFOX in Subjects With Advanced GI Malignancies Focusing on Hepatocellular Carcinoma

Who this might be right for
Advanced Gastrointestinal (GI) MalignanciesHepatocellular CarcinomaGastric Cancer+1 more
Polaris Group 140
Not applicableStudy completedNCT00857805
What this trial is testing

Transarterial Chemoembolization Versus Proton Beam Radiotherapy for the Treatment of Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Loma Linda University 76
Testing effectiveness (Phase 2)Looking for participantsNCT07219459
What this trial is testing

Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 Failure

Who this might be right for
Unresectable or Metastatic Hepatocellular CarcinomaChild-Pugh A Hepatocellular CarcinomaFailure of First-Line Treatment That Included an Approved Anti PD-(L)1 Compound
CatalYm GmbH 104
Next Page